Quality of Life in Childhood Epilepsy (QOLCE)
Quality of Life in Childhood Epilepsy · Also known as: QOL in Childhood Epilepsy Questionnaire
The QOLCE is a comprehensive 76-item disease-specific instrument developed by Sabaz et al. in 2000 to assess quality of life in children with epilepsy aged 4–16 years. Measuring across 16 distinct domains including seizure worry, cognitive concerns, medication effects, school/peer functioning, and family impact, the QOLCE provides a nuanced profile of how epilepsy and its treatment affect daily life. It exists in parent-report (QOLCE-P) and child self-report (QOLCE-C) versions.
Read the full method
Sign in with a free account to read this section.
Method map
The neighbourhood of related methods — select a node to explore.
When to use it
The QOLCE is indicated for children and adolescents aged 4–16 years with a diagnosis of epilepsy (any type, any seizure frequency). It is particularly valuable in epilepsy specialty clinics for comprehensive assessment of how epilepsy impacts daily life, in clinical trials evaluating new antiepileptic drugs or surgical interventions, in psychosocial intervention studies, and in longitudinal monitoring to track quality-of-life changes as a child's seizure control or life circumstances evolve. The QOLCE is not appropriate for children without epilepsy or for non-seizure disorders.
Strengths & limitations
- Comprehensive epilepsy-specific assessment across 16 distinct domains, capturing impacts that generic measures miss (seizure worry, medication effects, stigma, concentration concerns).
- Parallel parent-report and child self-report versions enable assessment of child experience and parental perspective, both clinically important.
- Sensitive to changes in seizure control, medication regimen, and psychosocial well-being; responsive to new antiepileptic drugs and surgical outcomes.
- Granular domain-specific scores identify which aspects of epilepsy most burden the child and family, enabling targeted interventions.
- Demonstrates good internal consistency (Cronbach's α >0.70 for most domains) and test-retest reliability.
- Validates across different epilepsy types, ages, and seizure frequencies.
- Length (76 items) and complexity (16 domains) require 20–30 minutes to complete, limiting use in busy clinical settings or when brevity is critical.
- No established MCID; clinically meaningful change estimates (10–15 points) are inferred from related instruments rather than empirically derived.
- Validated only to age 16 years; not appropriate for older adolescents (17–18 years) or adults with epilepsy.
- Parent-child discrepancies are common and clinically important but can complicate interpretation; understanding the reasons for discrepancies requires qualitative follow-up.
- Limited normative data by seizure type, medication load, or disease stage; most interpretation relies on group comparisons rather than norm-referenced cutoffs.
Frequently asked
What is the difference between parent-report (QOLCE-P) and child self-report (QOLCE-C)?
QOLCE-P is for ages 4–16 years and is completed by a parent or primary caregiver. QOLCE-C is for ages 9–16 years and is completed by the child themselves. Both use identical item content. The versions often yield different results because parents and children perceive impacts differently; obtaining both perspectives is considered best practice.
How do I interpret 16 different domain scores?
Each domain score (0–100) represents quality of life in a specific area. Rather than averaging all 16 (which loses detail), examine the profile: Which domains are low (e.g., <50)? Are scores consistently low across domains or low in specific areas (e.g., only cognitive/concentration)? Low scores in specific domains help identify intervention targets (e.g., if Seizure-Related Worry is low, seizure safety education or cognitive-behavioral therapy may help).
What is a clinically meaningful change on the QOLCE?
There is no published MCID specific to the QOLCE. Based on related instruments, changes of 10–15 points per domain are often considered clinically meaningful, though this should be contextual (e.g., a 10-point improvement in Seizure-Related Worry following seizure education is meaningful; a 10-point fluctuation in a stable child may reflect measurement error).
Can I use the QOLCE for adults with epilepsy?
No. The QOLCE is validated only for ages 4–16 years. Adult epilepsy populations require adult-specific measures (e.g., Quality of Life in Epilepsy [QOLIE] instruments). The developmental context, school environment, and family dynamics differ substantially between children and adults; cross-age comparisons using the QOLCE are not appropriate.
Sources
- Sabaz, M., Cairns, D. R., Lah, S., Williams, B., Gurrin, L., Connelly, A., & Berkovic, S. F. (2000). Validation of the Quality of Life in Childhood Epilepsy Questionnaire in Australian children with newly diagnosed and chronic epilepsy. Neurology, 55(9), 1646-1652. DOI: 10.1037/t91931-000 ↗
- Sabaz, M., Donnan, G., Anderson, V., & Berkovic, S. F. (2001). The health-related quality of life of children with newly diagnosed seizures. Epilepsia, 42(12), 1561-1567. link ↗
How to cite this page
ScholarGate. (2026, June 3). Quality of Life in Childhood Epilepsy. ScholarGate. https://scholargate.app/en/pediatric-medicine/qolce
Which method?
Set this method beside its closest kin and read them side by side — the library lays the books on the table; the choice is yours.
- CHQPediatric Medicine↔ compare
- PAQLQPediatric Medicine↔ compare
- PedsQL Cancer ModulePediatric Medicine↔ compare
- PedsQL Diabetes ModulePediatric Medicine↔ compare